It is with deep gratitude and admiration that we thank Brian Underdown for his years of service as a member of the CQD Scientific Advisory Board (SAB) since 2019 and as SAB Chairman since June 2021.Under Brian’s leadership, 49 projects have been recommended by the SAB, representing a total value of $85M. These projects brought…
Announcement Montréal, December 10th, 2024 – CQDM is pleased to announce the funding of a collaborative research project between Novatek International and the National Research Council of Canada (NRC). The collaboration will leverage the expertise of NRC researchers, Vincent Gagnon Shaigetz and Nushi Choudhury, in virtual reality software development for cognitive health. Together, the project…
Announcement Montréal, November 28th – CQDM is proud to announce a strategic partnership with the D2R (DNA to RNA) Initiative at McGill University, aimed at funding translational research projects carried out through collaborations between researchers and industry. This alliance seeks to support and accelerate the development and commercialization of innovative RNA-based therapies. It aims to…
ANNOUNCEMENT Montreal, November 22, 2024 – CQDM is proud to announce that the collaborative R&D project, which developed an AI-powered multimodal prognostic platform to predict disease progression, has won the Industrial Research Sectoral Groups (RSRI) Innovation Award at the 34th ADRIQ Gala held last night at the Palais des congrès de Montréal. This collaborative R&D…
CQDM attended NeuroSphere Demo Day on November 8. Mathieu Paquette, Ph.D., M.B.A., Director of Business Development and Quebec Team Lead, who supports numerous startups daily, shared his experience on a panel discussing “The Path to Commercialization for Impact-Oriented Startups.”Simon Fournier, MSc, MBA, also Director of Business Development at CQDM, had the opportunity to present CQDM’s…
We are thrilled to welcome Jeanne Ouellet-Ayotte, our new Marketing and Communications Coordinator! With a background in photography and graphic design, Jeanne specializes in branding, combining creative conceptualization with strategic positioning to maximize marketing campaign impact. Over the past ten years, she has worked independently as an art director, collaborating with prestigious clients such as…
We are thrilled to welcome Xavier Linker, our new Director of Strategic Initiatives. Xavier brings a dual background in science and management, with an engineering degree in biochemical engineering complemented by a Specialized Master’s in Biotechnology Management. He began his career in business development, holding various roles within preclinical contract research organizations in France and…
Announcement Montreal, November 7, 2024 – CQDM is proud to announce the funding of a collaborative research project aimed at promoting the development of an academic antibody characterization platform to facilitate research and development of new drugs in neuroscience. This project, valued at nearly $4.1 million, is made possible in part by a grant from…
News Release Montreal, October 15, 2024 – CQDM and Brain Canada are proud to announce the funding of three collaborative research projects, for a total of $7.4 million which includes financial support from various industry partners, aimed at addressing unmet needs in the treatment of brain disorders. These projects are made possible by a contribution…
Montreal, Quebec, 26 September 2024 – CQDM and Epitopea, a transatlantic cancer immunotherapy company, are proud to announce the launch of a collaborative research project between Epitopea and Université de Montréal (UdeM), a leading Canadian research institution renowned for scientific innovation and technology transfer. Together, they will examine the feasibility of developing new immunotherapies to effectively…